Brighton, MA, 21353,
United States
Moma Therapeutics Technographics
Moma Therapeutics Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Moma Therapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10 Moma Therapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Moma Therapeutics has purchased the following applications: Greenhouse ATS for Applicant Tracking System in 2021, Microsoft 365 for Collaboration in 2020, Egnyte Life Sciences for Content Management in 2023 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Moma Therapeutics is running and its propensity to invest more and deepen its relationship with Greenhouse , Microsoft , Salesforce or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Moma Therapeutics revenues, which have grown to $1.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Moma Therapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Moma Therapeutics Tech Stack and Enterprise Applications
Moma Therapeutics HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Greenhouse | Legacy | Greenhouse ATS | Applicant Tracking System | HCM | n/a | 2021 | 2021 |
|
Moma Therapeutics Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2020 | 2020 |
|
|
|
|
|
Collaboration | Collaboration |
|
2022 | 2022 |
|
|
|
|
|
Survey and Questionnaire | Collaboration |
|
2021 | 2021 |
|
Moma Therapeutics Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Egnyte | Legacy | Egnyte Life Sciences | Content Management | Content Management | Pliancy | 2023 | 2023 |
In 2023, Moma Therapeutics implemented Egnyte Life Sciences under the Content Management category to secure lab to cloud data flows and streamline collaboration with contract research organizations for R&D and clinical operations in the United States. The deployment targeted ingestion of data from lab instruments and external collaborator access, and the program reduced internal support tickets related to file sharing and access.
Configuration centered on secure external collaborator access, lab data governance, and instrument data ingestion pipelines rather than electronic quality management functionality. Egnyte Life Sciences was configured to apply access controls, role based provisioning, data classification and audit logging to scientific datasets and clinical trial artifacts. Workflows emphasized controlled sharing of raw and processed research files and orchestration of CRO collaboration without introducing eQMS modules.
The implementation was delivered with IT services partner Pliancy and operated across Moma Therapeutics research and clinical teams in the United States. Governance changes included standardized external user onboarding, policy driven sharing, and operational support adjustments that reduced support ticket volume after go live. Integrations focused on ingesting laboratory instrument outputs into the Content Management platform to centralize R&D data flows and enable secure file exchange with CROs.
|
Moma Therapeutics CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Support | CRM |
|
2020 | 2020 |
|
|
|
|
|
Marketing Automation | CRM |
|
2021 | 2021 |
|
|
|
|
|
Tag Management | CRM |
|
2022 | 2022 |
|
Moma Therapeutics ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
IT Service Management | ITSM |
|
2021 | 2021 |
|
Moma Therapeutics IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
Moma Therapeutics CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Moma Therapeutics
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Moma Therapeutics Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||